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To evaluate the predictors and likelihood of success for 
coronary angioplasty performed in the setting of acute 
myocardial infarction, 300 consecutive patients with 321 
coronary stenoses were studied retrospectively. Success was 
defined as final diameter stenosis <70% and Thrombolysis 
in Myocardial Infarction (TIMI) flow grade ~2. Nine 
clinical variables and 15 angiographic variables were as-
sessed. Seventy-nine percent of patients were men; the 
mean age was 56 ± 11 years, and 54% of patients also 
received thrombolytic therapy. The mean left ventricular 
ejection fraction was 46 ± 11 %, and 18 patients (6 % ) were 
in cardiogenic shock. 
Angioplasty success in the infarct-related artery was 
achieved in 240 patients (80%). In 177 total occlusions 
(TIMI flow grade ::;1), the success rate was 75.7% and 
success was independently predicted by 1) an ejection 
fraction >30% (p = 0.001); 2) no arterial bend ~45° at the 
site of angioplasty (p = 0.008); and 3) no triple vessel 
disease (p = 0.014). In 144 subtotal occlusions (TIMI flow 
grade ~2), procedural success was achieved in 84.7% and 
The role of coronary angioplasty relative to thrombolytic 
and conventional therapy of acute myocardial infarction has 
yet to be completely defined, but angioplasty will probably 
be most useful in patients who have contraindications to or 
have been unsuccessfully managed with thrombolytic ther-
apy. Preliminary reports from several groups (1-11) suggest 
that restoration or improvement of infarct artery blood flow 
with angioplasty can be achieved in 72 to 97% of patients. 
However, with the possible exceptions of subtotal versus 
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was predicted by 1) absence of thrombus >5 mm (p = 
0.023), and 2) absence of other stenoses ~50% in the same 
artery (p = 0.043), whereas patency without further emer-
gency intervention was achieved in 71.7% and was pre-
dicted only by patient age ::;60 years and absence of 
cardiogenic shock. Time to angioplasty, the specific artery 
dilated and other angiographic features of the stenosis to be 
dilated were not important predictors of outcome. 
Knowledge of the likelihood of success may allow more 
judicious use of coronary angioplasty in this setting: in 
particular, 1) consideration of immediate bypass surgery in 
the presence of TIMI flow grade ::;1 and two or more risk 
factors for angioplasty failure (ejection fraction ::;30%, 
occlusion at a bend or triple vessel disease) or in-hospital 
surgical standby if surgery is not immediately available; 
and 2) avoidance of immediate angioplasty in the presence 
of a) well maintained coronary flow and no reason for high 
risk of reocclusion, b) a large thrombus, c) multiple steno-
ses in the artery to be dilated, or d) patient age >60 years. 
(J Am Coli CardioI1988;12:1407-15) 
total occlusion (3,6,7) and age ~70 years (8), predictors of 
angioplasty success in this setting have not been well de-
scribed. To assist in the assessment of the likelihood of 
success with coronary angioplasty before initiating this 
procedure with its attendant risks (3,7,8,11), we retrospec-
tively analyzed our results with 300 consecutively treated 
patients for correlates of procedural success and prehospital 
discharge arterial patency without further intervention (an-
gioplasty or bypass surgery). 
Methods 
Selection of patients. All patients with acute myocardial 
infarction treated by angioplasty within 48 h of symptom 
onset from January 1, 1985 until December 21, 1986 at the 
University of Michigan were considered for this analysis. 
Patients were excluded only if the procedural cineangiogram 
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was unavailable for review (n = 31) or if the pre- or 
postdilation cine angiogram was of insufficient quality to 
allow for quantitative analysis (usually because the angio-
graphic guide wire was still placed across the lesion at the 
time of the final cineangiogram) (n = 11). Consecutive 
patients were screened for entry into the study until 300 
patients fulfilled the study criteria. As judged by in-hospital 
mortality, incidence of emergency bypass surgery and clin-
ical characteristics, there was no bias of ascertainment 
induced by nonavailability or inadequate quality of cinean-
giograms. Ninety-three of these patients had participated in 
previously reported (4,7) or ongoing randomized trials as-
sessing interventions in acute myocardial infarction. Eighty-
two of these 93 patients had been randomized to receive 
recombinant tissue plasminogen activator (rt-PA) alone be-
fore angioplasty, 9 to receive rt-PA and urokinase before 
angioplasty and 2 to receive streptokinase before angio-
plasty. In addition, on the basis of clinical indications, 61 
patients received streptokinase before angioplasty. For all 
patients, angioplasty was performed under guidelines ap-
proved by the Committee to Review Grants for Clinical 
Research and Investigation at the University of Michigan 
Medical Center and after informed consent had been given. 
Indications for angioplasty. Two hundred eighty-two pa-
tients underwent coronary angioplasty because of persistent 
total occlusion or ongoing ischemia with chest pain or 
residual ST segment elevation, and 18 patients without 
apparent ongoing ischemia were randomized to coronary 
angioplasty after apparently successful thrombolysis. Pa-
tients were usually not considered for angioplasty in the 
presence of left main coronary disease with :::::60% diameter 
stenosis or in the presence of :::::70% stenoses of both the 
proximal left anterior descending and left circumflex coro-
nary arteries, or for a distal occlusion in a tortuous vessel 
that was believed not to be technically suitable for the 
procedure. Patients were not necessarily excluded because 
of advanced age or cardiogenic shock, but were usually 
excluded from receiving prior thrombolytic therapy on these 
bases. 
Angioplasty technique. All patients received sublingual 
nitroglycerin (0.4 mg) in the emergency room to exclude 
coronary spasm. Intravenous morphine was administered as 
required for chest pain. After the placement of a vascular 
sheath, 3,000 to 5,000 U of heparin was administered intra-
venously. Once it was determined that a patient's coronary 
anatomy was suitable for angioplasty, an additional 5,000 to 
7,000 U of intravenous heparin was given, and 115 patients 
received 5 mg of intravenous verapamil. Intracoronary ni-
troglycerin (0.2 mg) was also commonly administered during 
the procedures. 
Selective coronary angiography was performed in both 
the right and left anterior oblique projections with the use of 
multiple degrees of angulation and cranial-caudal obliquity. 
Contrast ventriculography, with the use of 30 to 45 ml of 
sodium meglumine (Renografin-76, Squibb) or iohexol (Om-
nipaque 350, Winthrop-Breon), was performed in the 30° 
right anterior oblique projection before completion of the 
procedure. 
After the initial coronary angiograms were obtained, a 
0.014 or 0.016 in. steerable guidewire was advanced by way 
of a guiding catheter to the coronary stenosis. The guidewire 
was used to gently probe the occlusion, and if little or no 
resistance was met, it was guided through the stenosis. The 
balloon catheter was then advanced and, if possible, the 
translesional pressure gradient was measured. The dilating 
balloon was then inflated serially until an adequate reduction 
of the stenosis had been accomplished. 
Patients were then treated with heparin for 3 to 10 days, 
aspirin (80 to 600 mg daily) and an oral calcium channel 
blocker and nitrates as tolerated. One hundred two patients 
were also maintained on an infusion of low molecular weight 
dextran (40 mUh) for 24 h. The vascular sheath was left in 
place for 24 h; then, if the patient was in clinically stable 
condition, the heparin infusion was stopped for 2 to 3 hand 
the sheath removed. The heparin infusion was then resumed 
after hemostasis had been achieved at the groin puncture 
site. 
All patients were initially monitored in the intensive care 
unit. Hemodynamic monitoring was performed and adjunc-
tive drug therapy was administered as clinically indicated. 
Further intervention (angioplasty or bypass surgery) was 
performed as clinically indicated, primarily if spontaneous or 
exercise-induced signs and symptoms of ischemia devel-
oped. 
Operator experience. All angioplasties were performed 
by one of six staff interventional cardiologists who were 
experienced in coronary angioplasty. The mean number of 
angioplasties performed by each operator at the mid point of 
this study was 295 ± 215 (total) and 78 ± 68 (in the setting of 
acute myocardial infarction). 
Data review. Clinical and procedural data had been pro-
spectively entered onto case report forms at the time of 
catheterization. These forms and patient charts were re-
viewed by an independent observer (L.G.), unaware of the 
quantitative angiographic outcome, to assure completeness 
and accuracy of the data. Nine clinical variables were 
analyzed: patient age, gender, diabetes mellitus, prior myo-
cardial infarction, location of infarction (anterior or inferior/ 
posterior), time from onset of chest pain to initiation of 
coronary angioplasty, prior use of an intravenous throm-
bolytic agent, systolic blood pressure on arrival in the 
cardiac catheterization laboratory and the presence, before 
angioplasty, of cardiogenic shock [defined as 1) systolic 
blood pressure :580 mm Hg after fluid administration, or 2) 
the need for pressor support and systolic blood pressure :589 
mm Hg]. 
Angiographic analysis. Quantitative measurement of per-
cent diameter coronary stenosis and abso,lute residual mini-
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mal diameter was performed by an experienced angiog-
rapher who used a validated automated quantitative system 
(12) and was unaware of clinical outcome. Pre- and postangio-
plasty percent stenosis and absolute minimal diameters were 
reported as mean values from orthogonal projections. 
In addition, the pre- and postangioplasty features of the 
infarct-related artery were assessed by an observer unaware 
of patient data for Thrombolysis in Myocardial Infarction 
(TIMI) flow grade (13) and 12 other previously defined 
angiographic or morphologic variables (14): artery dilated; 
proximal or nonproximal stenosis location; single, double or 
triple vessel disease by the >50% diameter stenosis defini-
tion; length, in millimeters, of the stenosis :::::50% narrowed; 
location of the stenosis at an end-diastolic bend :::::45"; branch 
point location; other stenoses :::::50% in the artery dilated; the 
preangioplasty presence of contrast staining or a filling 
defect suggestive of thrombus and its length in millimeters; 
collateral vessels to the artery dilated; diffuse disease in the 
artery dilated; calcification in the area of stenosis dilated and 
stenosis eccentricity. For the purposes of this study, patients 
with a preangioplasty TIMI flow grade :s 1 were said to have 
a total occlusion, and those with a preangioplasty TIMI flow 
grade :::::2 were said to have a subtotal occlusion. 
Procedural ventriculograms were analyzed for global left 
ventricular ejection fraction by means of the area-length 
method (CLC Version 6A, VVF analyses, Electronics for 
Medicine). End-diastolic and end-systolic frames were se-
lected by an observer (S.E., A.L.) unaware of patient data, 
and endocardial borders were digitized with the use of a 
light-pen system (15). 
When applicable, the reason for failed angioplasty was 
determined by review of the procedural record and associ-
ated cinangiograms. 
Statistical analysis. All data were entered into the Uni-
versity of Michigan Coronary Angioplasty in Acute Myocar-
dial Infarction Database, a relational data base, with use of 
SYSTAT Software (Wilkinson, Leland). Data are presented 
as mean values ± SD except where noted. Unpaired Stu-
dent's t tests and chi-square analyses were used to compare 
continuous and categorical single variables with outcome. 
Multiple stepwise linear regression analysis with alpha to 
enter and remove variables equals 0.15 (16) was used to test 
hypotheses regarding the independent effect of variables on 
angioplasty success. A two-tailed p :s 0.05 was considered 
significant, although values of 0.05 < P :s 0.15 are included 
in this study for completeness (17). 
Because not all morphologic data could be assessed for 
patients with a total occlusion, and because indications for 
angioplasty differ in the setting of total versus subtotal 
occlusion, the correlates of angioplasty success were ana-
lyzed separately for total and subtotal occlusions. Arterial 
patency before hospital discharge was assessed only for 
patients with predischarge angiography or patients who died 
before hospital discharge (artery assumed not patent). Pa-
Table 1. Patient and Stenosis Characteristics 
Patient characteristics (n = 3(0) 
Age (yr) 56.2 ± 10.8 
Gender (% male) 79.0 
Anterior myocardial infarction (%) 48.3 
Time to angioplasty (median, h) 4.8 (range 1 to 48) 
Prior myocardial infarction (%) 17.7 
Adjunctive thrombolytic therapy (%) 54.0 
Multivessel coronary artery disease (%) 49.0 
Systolic blood pressure before angioplasty (mm Hg) 114 ± 23 
Left ventricular ejection fraction (%) 46 ± 11 
Stenosis characteristics (n = 321) 
Vessel (%) 
Left anterior descending coronary artery 48.6 
Left circumflex coronary artery 10.6 
Right coronary artery 39.0 
Bypass graft 1.9 
Site (%) 
Proximal 49.2 
Mid or distal 50.8 
Preangioplasty % stenosis 89.1 ± 14.2 
Preangioplasty TIMI flow grade 1.3 ± 1.3 
tients without predischarge angiography were not included 
in these analyses. Results for predischarge vessel patency 
are expressed per patient, whereas results relating to proce-
dural success are expressed per artery dilated. 
Results 
Relevant patient and stenosis characteristics (Table 1). In 
addition to the angiographic data shown in Table 1, 16% of 
the stenoses were calcified, 31.5% had visible collateral 
vessels and, of the 144 subtotally occluded sites dilated, 31 % 
were at a bend, 42% were at a branch, 74% were eccentri-
cally located in the artery, 30% were located in an artery in 
which there were other :::::50% stenoses and 56% had angio-
graphically apparent thrombus (median thrombus length 3 
mm, range 1 to 12). 
Initial angioplasty results. Primary success, defined as a 
reduction in diameter stenosis to <70% and achievement of 
TIMI flow grade :::::2 in the infarct-related artery, was at-
tained in 240 (80%) of the 300 patients. Arterial patency, 
defined as the achievement of TIMI flow grade :::::2, was 
attained in 278 (87%) of 321 arteries dilated. The mean 
postangioplasty percent stenosis and TIMI flow grade were 
50.4 ± 24.6 and 2.4 ± 1.0, respectively (both p :s 0.001 
compared with preangioplasty). Twenty-one patients (7%) 
required emergency bypass surgery because of failed angio-
plasty. The overall in-hospital mortality rate was 9%. 
Patient course in the hospital (Fig. 1). Of the 170 patients 
with a total occlusion, 54% were discharged from the hospi-
tal with a patent artery and no further intervention. Of the 
l30 patients with a subtotal occlusion before angioplasty, 
72% were discharged from the hospital with a patent artery 
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Pre-PTCA TIMI Grade" 2 1 
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PTCA Success (n=129) PTCA Failure (n=41) PTCA Success (n=111) PTCA Failure (n=19) 
Ischemia 
Ischemia 
Ischemia 
PTCA (n=7) 
CABG (n=2) 
no intervention 
(n=l) / \ 
Total occlusion at follow-up 
(n=6) 
Died without CABG (n=13) 
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Elective CABG (n=2) \ 
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(n=33) 
Late patency 2 (n=81; 53.6%) 
Died 
(n=8) 
Figure 1. In-hospital outcome of coronary angioplasty (PTCA). lAt 
primary angioplasty site; 2without further emergent intervention 
(angioplasty or coronary artery bypass graft [CABG]). 
and no further intervention. Hospital survival in the 240 
patients with successful angioplasty was 93% compared with 
83% in the 60 patients in whom angioplasty failed (p = 0.02). 
Predictors of angioplasty success (Tables 2 and 3). The 
correlates of procedural success and prehospital discharge 
arterial patency without further intervention for patients with 
total occlusion are shown in Table 2, and for patients with 
subtotal occlusion in Table 3. The results do not differ when 
patients are classified as having received intravenous strepto-
kinase or urokinase (n = 72), intravenous recombinant tissue-
type plasminogen activator (rt-PA) (n = 82) or no intravenous 
thrombolytic therapy (n = 146) before angioplasty. 
Reasons for failed angioplasty (Table 4). The most com-
mon reasons for angioplasty failure were 1) failure to pass 
the wire beyond the stenosis, seen most often with total 
occlusion, triple vessel disease and ejection fraction :530%; 
and 2) recurrent thrombus, seen most commonly with sub-
total and proximal occlusions. Adjunctive use of thrombo-
lytic therapy did not reduce the likelihood of failure due to 
obstructive thrombus formation (thrombolytic therapy: 10 
[6.4%] of 156 versus no thrombolytic therapy: 9 [7.6%] of 
119, p = NS; failures due to other causes not included). 
Relation of operator experience to procedural success. 
There were only weak, nonsignificant correlations between 
angioplasty success and the total number of coronary angio-
plasties that had been performed by the operator (range 75 to 
700, r = 0.43) and between success and the number of 
angioplasties performed by the operator in the setting of 
acute myocardial infarction (range 15 to 200, r = 0.47). 
Discussion 
Reperfusion therapy administered in the setting of acute 
myocardial infarction has been shown to increase patient 
Ischemia PTCA (n=4) 
Ischemia CABG (n= 1) 
Total occlusion at 
follow-up (n=6) 
Died without CABG (n=2) 
Clinically well without 
follow-up angiography (n=12) 
Elective CABG (n=5) 
Late patency 2 (n=81; 71.7%) 
/\ 
Alive 
(n=17) 
Died 
(n=2) 
survival (18,19). Restoration of TIMI grade 2 coronary flow 
or greater has been achieved by thrombolytic therapy in up 
to 75% of patients (20), but thrombolysis often leaves a high 
grade stenosis that may impair recovery of myocardial 
function or possibly predispose patients to recurrent ische-
mic events (21-27). As primary treatment, coronary angio-' 
plasty is less readily available in a timely fashion than is 
thrombolytic therapy, but it may also achieve a 72 to 97% 
success rate (1-11). As an adjunct to thrombolytic therapy, 
angioplasty has the potential of diminishing the residual 
stenosis, albeit at a risk of producing a total occlusion of the 
vessel dilated. 
Comparison with previous studies. In the largest series of 
patients with acute infarction treated with angioplasty re-
ported in detail to date, Stack et al. (9) achieved procedural 
success in 87% of 216 patients and late patency without 
further intervention in 127 (64.5%) of 197 arteries using the 
definitions of this study. Detailed clinical and angiographic 
characteristics were not related to outcome. Rothbaum et al. 
(6) reported success in 87% of 151 patients and found 
success to be higher in patients with a subtotal compared 
with a total occlusion. In a preliminary report, Rutherford et 
al. (10), reporting results from a highly experienced angio-
plasty group, described success in 91% of patients but did 
not relate patient features to outcome. In none of these 
reports was percent diameter stenosis measured with quan-
titative techniques; therefore, assessment may have been 
subjected to unintentional observational bias (28). The re-
sults reported herein are comparable in terms of angioplasty 
success rate but, in addition, the results were analyzed to 
attempt to define which types of patients had successful or 
unsuccessful emergency angioplasty. 
Predictors of angioplasty failure. In this series, proce-
dural failure was most closely related to five factors: the 
presence of triple vessel disease, left ventricular ejection 
fraction :530%, coronary occlusion at a bend, thrombus >5 
mm and other stenoses in the occluded artery. For patients 
with triple vessel disease and an ejection fraction :530%, 
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Table 2. Predictors of Procedural Success and Arterial Patency With Initial TIMI Coronary Flow :S I 
% Success With % Success Univariate Multivariate 
Variable Variable Present Without Variable p Value p Value 
A. Predictors of Procedural Success 
Clinical 
Age :s60 yr 72.6 81.2 NS 
Male gender 76.0 74.3 NS 
Time :s6 h 76.1 74.3 NS 
Anterior infarction 75.3 76.1 NS 
Diabetes mellitus 73.6 75.9 NS 
Prior myocardial infarction 71.0 76.9 NS 
Prior thrombolytic therapy 78.4 73.8 NS 
Cardiogenic shock 71.4 76.5 NS 
Angiographic 
LAD 76.5 75.0 NS 
LCx 75.0 75.8 NS 
RCA 76.4 75.2 NS 
Bypass graft 33.0 76.4 NS 
Proximal site 69.6 84.0 0.027 
Triple vessel disease 56.1 81.6 0.001 0.014 
LVEF :s30% 50.1 80.9 <0.001 0.001 
Bend 58.6 79.0 0.019 0.008 
Branch 61.1 79.4 0.022 
Thrombus >5 mm 68.7 77.2 NS 
Collaterals 77.1 74.5 NS 
Calcification 68.8 77.2 NS 
B. Predictors of Arterial Patency at Hospital Discharget 
% Patent % Patent 
With Variable Without Variable 
Clinical 
Age :s60 yr 49.0 64.3 0.065 
Male gender 53.2 59.4 NS 
Time :s6 h 53.9 56.3 NS 
Anterior infarction 57.9 51.2 NS 
Diabetes mellitus 50.0 55.0 NS 
Prior myocardial infarction 46.9 56.3 NS 
Prior thrombolytic therapy 51.4 56.8 NS 
Cardiogel]ic shock 42.3 56.8 NS 
Angiographic 
LAD 58.7 50.6 NS 
LCx 55.5 54.3 NS 
RCA 50.0 57.3 NS 
Bypass graft 0.0 55.1 NS 
Proximal site 51.1 59.1 NS 
Triple vessel disease 28.6 61.8 <0.001 0.013 
LVEF :s30% 27.6 60.5 <0.001 0.004 
Bend 42.3 56.8 NS 
Branch 46.9 56.3 NS 
Thrombus >5 mm 53.1 54.8 NS 
Collaterals 57.9 51.2 NS 
Calcification 44.4 56.5 NS 
1411 
Multivariate 
Coefficient* 
-0.183 
-0.291 
-0.222 
-0.254:J: 
-0.271:J: 
*Constant = 0.885; twithout further emergency intervention (angioplasty or bypass surgery); :J:constant = 0.651. LAD = left anterior descending coronary 
artery; LCx = left circumflex coronary artery; LVEF = left ventricular ejection fraction; RCA = right coronary artery. 
failure to pass the wire across the occlusion accounted for 
the vast majority of procedural failures and may have been in 
large part related to the hemodynamic instability or diffuse-
ness of disease in these patients. Dilation at bend points or in 
an artery with multiple stenoses (both risk factors in elective 
angioplasty because of a propensity to cause dissection [14]) 
most often led to failure on the basis of dissection or 
recurrent thrombus. Finally, dilation at a site where a large 
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Table 3. Predictors of Procedural Success and Artery Patency With Initial TIMI Coronary Flow ?:2 
% Success With % Success Univariate 
Variable With Variable Present Without Variable p Value 
A. Predictors of Procedural Success 
Clinical 
Age :0:60 yr 83.7 86.2 NS 
Male gender 84.5 85.2 NS 
Time 56 h 84.8 84.4 NS 
Anterior infarction 82.2 87.3 NS 
Diabetes mellitus 78.9 85.6 NS 
Prior myocardial infarction 90.9 83.6 NS 
Prior thrombolytic therapy 86.3 80.9 NS 
Cardiogenic shock 8\.2 85.2 NS 
Angiographic 
LAD 83.1 86.3 NS 
LCx 85.7 84.6 NS 
RCA 85.7 84.1 NS 
Bypass grafts 100.0 84.4 NS 
Proximal site 82.1 86.4 NS 
Triple vessel disease 80.0 85.5 NS 
LVEF :0:30% 87.5 84.6 NS 
Stenosis >90% 74.1 87.2 0.088 
Other stenosis ;0:50% 76.7 88.1 0.083 
Lesion length ;0:10 mm 76.9 85.4 NS 
Bend 81.8 86.0 NS 
Branch 83.6 85.5 NS 
Thrombus >5 mm 61.5 87.0 0.015 
Collaterals 83.3 84.9 NS 
Diffuse disease 82.0 85.7 NS 
Calcification 73.6 86.4 NS 
Eccentric stenosis 85.9 81.1 NS 
B. Predictors of Artery Patency At Hospital Discharget 
% Patent % Patent 
With Variable Present Without Variable 
Clinical 
Age 560 yr 65.7 55.3 0.D2 
Male gender 69.5 61.5 NS 
Time 56 h 69.1 62.9 NS 
Anterior infarction 65.0 70.5 NS 
Diabetes mellitus 70.6 67.3 NS 
Prior myocardial infarction 90.9 67.9 NS 
Prior thrombolytic therapy 68.5 65.6 NS 
Cardiogenic shock 42.8 71.0 om 
Angiographic 
LAD 65.5 69.8 NS 
LCx 72.7 67.2 NS 
RCA 68.6 67.1 NS 
Bypass graft 100.0 67.5 NS 
Proximal site 64.8 70.3 NS 
Triple vessel disease 53.3 69.8 NS 
LVEF 530% 68.1 60.0 NS 
Diameter stenosis >90% 60.9 69.4 NS 
Other stenoses ;0:50% in same artery 58.3 68.8 NS 
Stenosis length ;0:10 mm 58.3 68.8 NS 
Bend 60.0 71.6 NS 
Branch 68.8 67.1 NS 
Thrombus >5 mm 60.0 68.5 NS 
Collaterals 70.6 67.3 NS 
Diffuse disease 60.6 70.4 NS 
Calcification 50.0 70.1 0.13 
Eccentric stenosis 65.6 74.2 NS 
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Multivariate Multivariate 
p Value Coefficient* 
0.070 -0.139 
0.043 -0.132 
0.023 -0.235 
0.006 -0.237:\: 
0.020 -0.299:\: 
0.084 -0.225:1: 
*Constant = 0.934; twithout further intervention (angioplasty or bypass surgery); :\:constant = 0.847. AbbreviatIons as in Tables I and 2. 
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Table 4. Reasons for Angioplasty Failure (n = 64) 
Triple Coronary 
Vessel Thrombus Other Stenoses Total Subtotal 
Disease LVEF <30% Bend >5 mm in Artery Occlusion Occlusion Total 
Failure to seat guide catheter 0 0 0 0 I 0 
Failure to pass wire 10 10 5 3 19 0 19 
Failure to dilate <70% 2 0 2 3 3 6 
Recurrent thrombus 5 6 9 5 13 6 19 
Dissection 2 0 5 4 3 8 11 
Thrombus or dissection 2 2 0 2 3 6 
VTNF during angioplasty 0 0 0 0 0 0 
Other I 0 0 0 0 0 
Total 22 16 20 15 16 43 21 64 
VF = ventricular fibrillation; VT = ventricular tachycardia; other abbreviations as in Table 2. 
amount of thrombus was already angiographically visible 
often led to propagation of that thrombus. 
A clinical algorithm for the use of angioplasty based on 
these results (Fig. 2). In the presence of total coronary 
occlusion, angioplasty is recommended unless two or more 
risk factors for failure (ejection fraction ::;30%, bend, triple 
vessel disease) are present, in which case emergency bypass 
surgery can be considered if the surgeon is experienced in 
the performance of bypass surgery in the setting of acute 
infarction (29-31) and surgery is immediately available. If 
surgery is not immediately available or if the cardiac surgeon 
is not experienced in the performance of bypass surgery in 
this setting, then angioplasty still can be undertaken, albeit 
with the understanding of a lessened likelihood of success. 
In such an instance, if the patient has a large amount of 
ischemic myocardium and is seen early in the course of 
infarction, in-hospital surgical standby might be advisable. 
In the presence of subtotal occlusion, the decision whether 
or not to perform angioplasty rests not only on the expected 
results of angioplasty, but also on the expected need for 
further intervention without angioplasty. These data suggest 
that a 93% initial success rate can be attained, decreasing to 
a 70 to 80% likelihood of success if a large thrombus or other 
stenosis in the same vessel is present (Table 3A). Patency 
rates at hospital discharge would be expected to be 85%, 
except in the presence of age >60 years, cardiogenic shock 
or artery calcification, when patency rates might decrease to 
55 to 65%. Limited reported experience with intracoronary 
and intravenous streptokinase (22-26) suggests that 17 to 
31 % of vessels will reclose and these results usually do not 
include patients who died (counted as closures in this series). 
From the data available after streptokinase administration, 
reclosure may occur in 30 to 50% of patients with a residual 
stenosis >60 to 70% or minimal luminal diameter 0.6 mm or 
in the presence of a large thrombus, but reclosure is much 
less likely in the absence of these risk factors. Reported 
experience with rt-PA and urokinase is still limited, but 
Topol et al. (7) reported an 18% incidence of reclosure after 
rt-PA that appears not to be closely linked to the previously 
mentioned risk factors (27). On the basis of these consider-
ations, it would seem prudent not to perform coronary 
angioplasty in the majority of patients unless the risk of 
vessel closure without angioplasty can be judged to exceed 
25 to 30%, and then only to apply angioplasty judiciously, 
avoiding it in the presence of a large amount of apparent 
thrombus, in arteries with multiple stenoses or in patients 
>60 years old. For patients who have had reperfusion 
established with intravenous rt-PA, assessment of risk of 
closure without angioplasty may be problematic and angio-
plasty should be deferred (27). 
Limitations. This study is limited by its retrospective 
nature, by the potential bias in results induced by patient 
selection and by the analysis of multiple variables. The 
relatively large patient number and variety may reduce the 
Pre-angioplastv TIMI Grade < 1 Pre-angioplasty TIMI Grade> 2 
Figure 2. Guideline to indications for angio-
plasty use in acute myocardial infarction assum-
ing a large amount of jeopardized myocardium, 
early catheterization and an experienced angio-
plasty operator. aFor patients who have received 
intravenous recombinant tissue plasminogen ac-
tivator, such stratification may not be possible 
and angioplasty should be deferred. 
Likelihood of angioplasty Success 
Low: 
(;'2 of: LVEF ';30%, 
bend, triple 
vessel disease) 
/ 
Consider Bypass Surgery 
or in hospital 
surgical standby 
(if experienced 
and available) 
Moderate-High: 
(,;1 of risk factors) 
\ 
PTCA 
Likelihocxl of Reclosure without angioplastya 
Low-Moderate (,;25%) 
I 
NoPTCA 
High (>25%) 
\ 
PTCA unless 
large thrombus, 
other stenoses 
in artery, or 
age> 60 years 
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importance of selection bias, and the readily apparent reason 
for the importance of each of the predictive variables should 
lessen the risk of a type 2 error. The diversity of patients 
examined reflects clinical practice, but the results reported 
may not apply equally to all subgroups of patients or to all 
types of adjunctive therapies. However, the use of throm-
bolytic agents did not influence outcome in any analysis. 
Finally, these results should not be extrapolated to those 
expected for low frequency angioplasty operators (32). 
Implications. Recently published randomized trials (7, II) 
show that emergency angioplasty need not be performed 
after successful thrombolysis with rt-PA in acute myocardial 
infarction. However, for the 30 to 40% of patients who are 
unsuccessfully managed with (7,13) or have contraindica-
tions to thrombolytic therapy, coronary angioplasty offers an 
often successful alternative. Our results indicate that angio-
plasty should have a role in the management of patients with 
acute infarction, that it should be avoided in patients with a 
subtotal coronary occlusion who have a low to moderate 
likelihood of reclosure without angioplasty or have a large 
amount of apparent thrombus or multiple stenoses in the 
infarct-related artery and perhaps in certain high risk pa-
tients with total occlusion if immediate bypass surgery is 
available. Finally, these results stress the need to find better 
pharmacologic means of preventing recurrent clot formation 
in this setting. 
We extend particular appreciation to Sheree Wilson, Judy Hanson and 
Vanessa Sims for the preparation of the manuscript. 
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